BCI® Therapy is being developed to restore thought-driven movement in people living with spinal cord injuries and other ...

LumiMind debuts real-time non-invasive brain computer interfaces at CES 2026, pairing live gameplay demos with LumiSleep, a ...

OpenAI recently confirmed that it has invested in its co-founder Sam Altman's Merge Labs, a brain computer interface startup.

OpenAI has invested in Merge Labs, a brain-computer interface (BCI) startup co-founded by OpenAI CEO Sam Altman. The startup ...

Growth is fueled by breakthroughs in non-invasive EEG and fNIRS systems, hybrid BCIs, and graphene-enabled electrodes that ...

The growing adoption of BCI technology is attributable to its rising awareness in treating a wide range of brain disorders. The growing incidences of brain disorders, stroke, depression, and Parkinson ...

In August, the Financial Times reported that OpenAI Chief Executive Officer Sam Altman is part of Merger Labs’ founding team ...

Lewes, Delaware, Jan. 07, 2026 (GLOBE NEWSWIRE) -- The Global Brain Computer Interface (BCI) Market Size is projected to grow at a CAGR of 14.61 % from 2026 to 2032, according to a new report ...

Precision Neuroscience today announced a strategic partnership with Medtronic to leverage brain-computer interface (BCI) ...

The OpenAI CEO is adding a well-funded brain-computer interface startup to his growing portfolio of ambitious bets.

OpenAI is participating in a $250 million seed round into Merge Labs, Sam Altman's brain computer interface startup. The ...

OpenAI (OPENAI) announced on Thursday that it has invested in brain computer interface startup Merge Labs, which includes ...